Extended endometrial ablation risks in the fertility sparing management of adenocarcinoma and atypical hyperplasia of the endometrium

被引:1
|
作者
Gonthier, C. [1 ,2 ]
Luton, D. [1 ,2 ]
Koskas, M. [1 ,2 ]
机构
[1] Hop Bichat Claude Bernard, AP HP, Serv Gynecol Obstet, F-75018 Paris, France
[2] Univ Paris 07, F-75018 Paris, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2015年 / 43卷 / 03期
关键词
Endometrial cancer; Endometrial atypical hyperplasia; Fertility-sparing management; Hysteroscopic resection; Endometrial ablation; CANCER;
D O I
10.1016/j.gyobfe.2015.01.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:185 / 186
页数:2
相关论文
共 50 条
  • [1] Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review
    Koskas, Martin
    Yazbeck, Chadi
    Walker, Francine
    Delorme, Pierre
    Azria, Elie
    Luton, Dominique
    Madelenat, Patrick
    [J]. BULLETIN DU CANCER, 2012, 99 (01) : 51 - 60
  • [2] PROGNOSTIC FACTORS IN FERTILITY-SPARING MANAGEMENT OF ENDOMETRIAL ATYPICAL HYPERPLASIA AND ADENOCARCINOMA RESTRICTED TO ENDOMETRIUM: SYSTEMATIC REVIEW
    Gonthier, C.
    Popescu, N.
    Koskas, M.
    Luton, D.
    Uzan, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1273 - 1273
  • [3] Fertility-sparing management of endometrial cancer and atypical hyperplasia
    Gonthier, C.
    Trefoux-Bourdet, A.
    Luton, D.
    Koskas, M.
    [J]. GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 112 - 118
  • [4] Fertility sparing management of endometrial complex hyperplasia and endometrial carcinoma
    Alan Farthing
    [J]. World Journal of Obstetrics and Gynecology, 2014, (02) : 42 - 44
  • [5] Fertility-Sparing Management of Endometrial Adenocarcinoma
    Dorais, Jessie
    Dodson, Mark
    Calvert, Jacob
    Mize, Benjamin
    Travarelli, Jennifer Mitchell
    Jasperson, Kory
    Peterson, Charles Matthew
    Soisson, Andrew P.
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2011, 66 (07) : 443 - 451
  • [6] Impact of In Vitro Fertilization treatments on the risk of recurrence in fertility-sparing management of endometrial atypical hyperplasia and grade I adenocarcinoma
    Vaugon, M.
    Peigne, M.
    Larouzee, E.
    Phelippeau, J.
    Gonthier, C.
    Koskas, M.
    [J]. HUMAN REPRODUCTION, 2020, 35 : 19 - 20
  • [7] A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma
    Guillon, Sarah
    Popescu, Nathalie
    Phelippeau, Juliette
    Koskas, Martin
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 277 - 288
  • [8] Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
    Chen, Junyu
    Cao, Dongyan
    Yang, Jiaxin
    Yu, Mei
    Zhou, Huimei
    Cheng, Ninghai
    Wang, Jinhui
    Zhang, Ying
    Peng, Peng
    Shen, Keng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Quality of information and decision regret during fertility sparing management for atypical hyperplasia and endometrial cancer
    Haim, Noemie
    Vandenbroucke, Tineke
    Bourdet, Alice
    Amant, Frederic
    Koskas, Martin
    [J]. PSYCHO-ONCOLOGY, 2017, 26 : 70 - 70
  • [10] Fertility-sparing treatment in a young patient with complex atypical hyperplasia of the endometrium
    Du Toit, G. C.
    [J]. SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 6 (01) : 30 - 32